Posts

Showing posts from April, 2022

Dr. Oz bought thousands of doses of hydroxychloroquine during pandemic - New York Post

Image
Dr. Mehmet Oz personally bought thousands of dollars worth of hydroxychloroquine during the height of the coronavirus pandemic. In March 2020, Oz spent $8,800.00 on 2070 tablets of the drug. The purchase came at a time when the TV doctor was heavily promoting the anti-Malaria drug as a possible treatment for the deadly virus. His advocacy even reached the White House which confirmed Trump was taking the drug in May of that year. Oz's campaign confirmed the purchase and said the doctor had been trying to help Columbia University with a study. "At the outset of the pandemic, Dr. Mehmet Oz spoke with health experts worldwide who were seeing hydroxychloroquine and azithromycin as viable treatment options for desperately ill COVID patients. He offered to fund the clinical trial at Columbia University," Brittany Yanick, Oz's Communications Director told The Post. The campaign said Oz had been prepared to spend $250

USC Upstate News - University of South Carolina Upstate

Image
The University of South Carolina Upstate hosted its 18th annual Research Symposium on Friday, April 8. At least 300 students, faculty and community members from across the Upstate region and beyond descended on USC Upstate's campus to network and share information about their research and scholarly or creative works. "The Research Symposium is critically important to USC Upstate," said Bennie L. Harris, Ph.D., chancellor of USC Upstate. "What makes a regional comprehensive like ours so unique is the tapestry of experiences we represent. As an institution we must continue to amplify all we do to encourage individuals to think and innovate." The symposium, which was held virtually in 2020 and 2021 due to the COVID-19 pandemic, returned to its live format this year with one important addition—a career fair featuring more than a dozen employers from across the state. The list included Spartanburg-based Milliken & Co., Bausch a

Melinta Therapeutics Acquires U.S. Rights to TOPROL-XL® (metoprolol succinate) from New American Therapeutics - Business Wire

Image
MORRISTOWN, N.J.--( BUSINESS WIRE )--Melinta Therapeutics, LLC ("Melinta"), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that it has acquired the U.S. rights to TOPROL-XL ® (metoprolol succinate) and its Authorized Generic (AG) through an agreement between Melinta and New American Therapeutics Inc. TOPROL-XL ® , approved by the FDA in 1992, is a cardioselective beta-blocker indicated for the treatment of hypertension, alone or in combination with other antihypertensives; the long-term treatment of angina pectoris; and the treatment of stable, symptomatic (NYHA class II or III) heart failure of specific origins. Said Christine Ann Miller, President and Chief Executive Officer, Melinta Therapeutics, "This acquisition immediately expands and diversifies our existing portfolio and serves as fuel for accelerating our long-term growth strategy and enhancing our profitability. We will continue to

Walmart Has Blocked or Delayed Some Adderall Prescriptions — Best Life - Best Life

Image
Whether for their vast variety of merchandise or for their guaranteed low prices, Walmart is many people's go-to stop for every and any household item. But many people also utilize the retailer when it comes to their health and wellness needs. Walmart has more more than 5,000 pharmacy locations across the U.S., making it an obvious choice for consumers who want to pick up their prescriptions while also doing their grocery shopping. But if you frequently take advantage of this retailer's pharmacies, you might want to also take note of a new urgent warning from the company. Read on to find out what Walmart is alerting consumers to right now. RELATED: These Are All the Walmart Locations Closing Forever by the End of May. Shutterstock Walmart offers a number of services through its pharmacies. You can get your COVID vaccines, have an eye exam, or even get your teeth cleaned at some of this retailer's locations.&

Sulfamethoxazole Market Share 2022-2030| Key Players – Roche, Polfa Pabianice, Ascot Pharma, Mylan – Ripon College Days - Ripon College Days

Image
New Jersey, USA,-  The research study presented here is a very detailed and meticulous description of almost all major aspects of the global Sulfamethoxazole market. It digs deep into market dynamics including growth drivers,challenges,restraints,trends and opportunities. Market participants can use research studies to strengthen their grip on the global Sulfamethoxazole market by gaining a sound understanding of market competition, regional growth,Sulfamethoxazole market segmentation, and various cost structures. This report provides an accurate market outlook with respect to average annual,market size by value and volume,and Sulfamethoxazole products market share. It also provides carefully calculated and verified market figures related to,but not limited to,revenue,production, consumption, gross margin and price. As part of the Global economic outlook,this report illuminates current and future market scenarios for Sulfamethoxazole products to consider when planning busine

New data for Roche's OCREVUS (ocrelizumab) show benefit in disability progression and cognitive decline in both secondary progressive and primary progressive multiple sclerosis - GlobeNewswire

Image
75% of patients with secondary progressive multiple sclerosis (SPMS) and primary progressive MS (PPMS) achieved no evidence of progression (NEP) in a one-year interim analysis of CONSONANCE study 70% of patients with SPMS and PPMS demonstrated stable or improved cognition after one year of OCREVUS treatment in CONSONANCE Separate analysis on treatment disparities showed fewer Black and Hispanic patients with MS initiate high-efficacy treatments within two years of diagnosis Data at AAN support the body of evidence for OCREVUS more than 450,000 patient years and more than 225,000 patients treated globally Basel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new OCREVUS® (ocrelizumab) data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis (PPMS) and secondary progressive MS (SPMS). Separate analyses on treatment disparities among newly diagnosed patients with MS by race and ethnicity will be a platform pre

Retained Placenta and Postpartum Hemorrhage: A Case Report and Review of Literature - Cureus

Image
The third stage of labor (delivery of the placenta), per current definition, takes place within 30 minutes of fetal delivery in a nulliparous or multiparous woman. According to the American Pregnancy Association, a retained placenta is diagnosed if the placenta is not delivered within 30 minutes following delivery of the fetus. Retained placenta can be caused by placenta accreta, increta, or percreta. There are several complications of a retained placenta, including postpartum hemorrhage, which can lead to maternal death if not treated promptly. We report the case of a 32-year-old female, gravida 4 para 3, who was diagnosed with a retained placenta after delivering at term (39 weeks gestation). The retained placenta was complicated by postpartum hemorrhage and was treated within 15 minutes of fetal delivery with several uterotonics (misoprostol, oxytocin, carboprost, and tranexamic acid) and several passes of ultrasound-guided suction curettage. Sharp curettage was also used

FDA Approves Benzoyl Peroxide Cream for Treatment of Inflammatory Lesions of Rosacea - Pharmacy Times

Image
With Epsolay treatment, inflammatory lesions of rosacea were reduced by nearly 70% by the end of both 12-week trials compared with a 38% to 46% reduction with the vehicle cream. The FDA has approved benzoyl peroxide cream 5% (Epsolay; Sol-Gel Technologies and Galderma) for the treatment of inflammatory lesions of rosacea in adults, according to a press release. The benzoyl peroxide in Epsolay is encapsulated within silica-based patented microcapsules and is designed to slowly release benzoyl peroxide over time to provide a favorable efficacy and safety profile, according to the manufacturers. The approval is supported by data from 2 positive, identical phase 3 randomized, double-blind, multicenter, 12-week clinical trials that evaluated Epsolay in individuals with inflammatory lesions of rosacea. "People with rosacea experience a significant burden of disease with diminished quality of life and the approval of Epsolay represents an important advancement for those who are living

Mircera (methoxy polyethylene glycol-epoetin beta) Drug / Medicine Information - News-Medical.Net

Image
(Pronounced "meer-seh-ra") Contains the active ingredient methoxy polyethylene glycol-epoetin beta Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Mircera. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Mircera against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. What Mircera